Antisense blockade of inducible nitric oxide synthase in glial cells derived from adult SJL mice

Neuroscience Letters

Volumn 220, Issue 2, 1996, Pages 89-92

  Ding, Minzhen ^a   Zhang, Ming ^a   Wong, Joyce L ^a   Voskuhl, Rhonda R ^a   Ellison, George W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adult; Antisense oligonucleotide; Glial cells; Inducible nitric oxide synthase; Interferon; Lipopolysaccharide; Multiple sclerosis; Nitric oxide

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CYCLIC GMP; GAMMA INTERFERON; LIPOPOLYSACCHARIDE; MESSENGER RNA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CONTROLLED STUDY; GENE EXPRESSION; GLIA CELL; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BASE SEQUENCE; CYCLIC GMP; INTERFERON TYPE II; LIPOPOLYSACCHARIDES; MICE; MOLECULAR SEQUENCE DATA; MULTIPLE SCLEROSIS; NEUROGLIA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OLIGONUCLEOTIDES, ANTISENSE;

EID: 0030582734     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(96)13229-8     Document Type: Article

References (23)

1. [1] Agrawal, S., Mayrund, S.H., Zamecnik, P.C. and Pedersen, T., Site-specific excision from RNA by RNase H and mixed-phosphate-backbone oligodeoxynucleotides, Proc. Natl. Acad. Sci. USA, 87 (1990) 1401-1405.
2. [2] Bo, L., Dawson, T.M., Wesselingh, S., Mork, S., Choi, S., Kong, P.A., Hanley, D. and Trapp, B.D., Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains, Ann. Neurol., 36 (1944) 778-786.
3. [3] Boiziau, C., Thuong, N.T. and Toulme, J.J., Mechanism of the inhibition of reverse transcription by antisense oligonucleotides, Proc. Natl. Acad. Sci. USA, 89 (1992) 768-772.
4. [4] Bolanos, J.P., Peuchen, S., Heales, S.J.R., Land, J.M. and Clark, J.B., Nitric oxide-mediated inhibition of the mitochondrial respiratory chain in cultured astrocytes, J. Neurochem., 63 (1994) 910-916.
5. [5] Boyle, E.A. and mcGeer, P.L., Cellular immune response in multiple sclerosis plaques, Am. J. Pathol., 137 (1990) 575-584.
6. [6] Bredt, D.S., Hwang, P.M., Glatt, C.S., Lowenstein, C.J., Reed, R.R. and Snyder, S.H., Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase. Nature, 351 (1991) 714-718.
7. [7] Chiang, M.Y., Chan, H., Zounes, M.A., Freier, S.M., Lima, W.F. and Bennett, C.F., Antisense oligonucleotides inhibit intercellular adhesion molecule 1 expression by two distinct mechanisms, J. Biol. Chem., 266 (1991) 18162-18171.
8. [8] Ellison, G.W., Immunosuppressive drugs. In S.D. Cook (Ed.), Handbook of Multiple Sclerosis, Vol. 2. Marcel Dekker, New York. 1996, in press.
9. [9] Galea, E., Reis, D.J. and Feisten, D.J., Cloning and expression of inducible nitric oxide synthase from rat astrocytes, J. Neurosci. Res., 37 (1994) 406-414.
10. [10] Garthwaite, J., Neural nitric oxide signalling, Trends Neurosci., 18 (1995) 51-52.
11. [11] Hibbs, J.B. Jr., Taintor, R.R., Vavrin, Z. and Rachlin, E.M., Nitric oxide: a cytotoxic activated macrophage effector molecule, Biochem. Biophys. Res. Commun., 157 (1988) 87-94.
12. [12] Lowenstein, C.J., Glatt, C.S., Bredt, D.S. and Snyder, S.H., Cloned and expressed macrophage nitric oxide synthase contrasts with the brain enzyme. Proc. Natl. Acad. Sci. USA, 89 (1995) 6711-6715.
13. [13] Mitrovic, B., Ignarro, L.J., Montestruque, S., Smoll, A. and Merrill, J.E., Nitric oxide as a potential pathological mechanism in demyelination: its differential effects on primary glial cells in vitro, Neuroscience, 61 (1994) 575-585.
14. [14] Murad, F., Regulation of cytosolic guanylyl cyclase by nitric oxide: the NO-cyclic GMP signal transduction system, Adv. Pharmacol., 26 (1994) 19-33.
15. [15] Murphy, S., Simmons, M.L., Agullo, L., Garcia, A., Feistein, D.L., Gallea, E., Reis, D.J., Minc-Golomb, D. and Schwartz, J.P., Synthesis of nitric oxide in CNS glial cells, Trends Neurosci., 16 (1993) 323-328.
16. [16] Nussler, A.K. and Billiar, T.R., Inflammation, immunoregulation, and inducible nitric oxide synthase, J. Leukocyte Biol., 54 (1993) 171-178.
17. [17] Palmer, R.M.J., Ashton, D.S. and Moncada. S., Vascular endothelial cells synthesize nitric oxide from L-arginine, Nature, 333 (1988) 664-666.
18. [18] Palmer, R.M.J., Ferrige, A.G. and Moncada, S., Nitric oxide release accounts for the biological activity of endotherium-derived relaxing factor, Nature, 327 (1987) 524-526.
19. [19] Raine, C.S. and The Dale, E., McFarlin memorial lecture: the immunology of the multiple sclerosis lesion, Ann. Neurol., 36 (1994) s61-s72.
20. [20] Simmons, M.L. and Murphy, S., Induction of nitric oxide synthase in glial cells, J. Neurochem., 59 (1992) 897-905.
21. [21] Traccy, W.R., Spectrophotometric detection of nitrogen oxides using azo dyes, Neuroprotocol: Methods Neurosci., 1 (1992) 125-131.
22. [22] Wong, J.M. and Billiar, T.R., Regulation and function of inducible nitric oxide synthase during sepsis and acute inflammation. In L.J. Ignarro and F. Murad (Eds.), Nitric Oxide: Biochemistry, Molecular Biology, and Therapeutic Implications. Academic Press, San Diego. CA. 1995, pp. 155-170.
23. [23] Zhang, M. and Creese, I., Antisense oligodeoxynucleotide reduces brain dopamine D2 receptors: behavioral correlates, Neurosci. Lett., 161 (1993) 223-226.